ÂÜÀòÂÒÂ×

Dr. Jacobs brings to Oculis more than 20 years of leadership experience in drug development. He joins us from Osmotica Pharmaceuticals, where he was Vice-President of Clinical Development and Medical Affairs since 2017. During his tenure, in addition to leading the clinical programs from phase I to IV in several therapeutic areas including ophthalmology, he was a key contributor to successful FDA submissions and market approvals, a key experience. Prior to his role at Osmotica, Dr. Jacobs held drug development leadership roles at Daiichi-Sankyo Pharmaceuticals, Aptalis Pharmaceuticals, Johnson & Johnson and King Pharmaceuticals.